RecruitingNot ApplicableNCT07214467

Individualized Adaptive Deep Brain Stimulation in Opioid Use Disorder

Sponsor

University of California, San Francisco

Enrollment

6 participants

Start Date

Oct 24, 2025

Study Type

INTERVENTIONAL

Conditions

Substance Use Disorder (SUD)Opioid Use Disorder (OUD)

Summary

The purpose of this study is to determine if personalized (adaptive) Deep Brain Stimulation (DBS) based upon invasive brain mapping is safe and can lead to better outcomes like reductions in craving and opioid use.

Eligibility

Min Age: 22 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Deep Brain Stimulation for people with opioid use disorder (oud) and substance use disorder (sud). The study is currently recruiting participants at 1 location. People eligible for this study include aged 22 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDeep Brain Stimulation

An individualized aDBS protocol will be used to examine therapeutic effect.

Locations(1)

University of California, San Francisco

San Francisco, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07214467

Related Trials

Reducing Parental Substance Use and Enhancing Family Resilience Among Rural Families Through Ohio START

NCT072784271 location

Safety and Feasibility of Next-Generation Dome Helmet (NGDH) for Focused Ultrasound Neuromodulation in Substance Use Disorder (SUD)

NCT076849761 location